Middlebrook Pharmaceuticals (MBRK) Obtains 100M Investment for Commercialization of MOXATAGä
Middlebrook Pharmaceuticals discovered in 2000 that bacteria exposed to antibiotics in front-loaded, sequential bursts, or pulses, are killed more efficiently…